Authors


Hossam Maksoud, PharmD

Latest:

Pharmacists Can Help Mitigate Pre-Exposure Prophylaxis Drug Concerns With Education, Adherence Assistance

Pharmacists play an important role in providing education and support with adherence to PrEP in populations with a high risk for HIV infection.



Jing Wu

Latest:

Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health Outcomes

Additional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.


Ryan Haumschild, PharmD, MS, MBA

Latest:

Build a Successful Biosimilar Adoption Plan

Many health care systems use these products to provide similar but cheaper clinical outcomes.


Andres Moreno

Latest:

Infusion Centers Must Be Proactive to Reduce Risks

There are several key areas of risk that infusion practices are likely to face at some point, and proactively preparing for these events can help ensure a positive outcome.


Matthew Marshall

Latest:

How Stakeholders Can Maximize the Value of Real-World Data Analytics

Analytics allow for a better understanding of the needs of various patient populations and the barriers they face in accessing care.


Oluwaseyi Egbewande, PharmD Candidate

Latest:

The Role of the Pharmacist in Herpes Zoster Vaccination

Pharmacists as immunizers are vaccine distributors, educators, facilitators, and administrators.


Marilyn Bulloch, PharmD, BCPS, FCCM, SPP

Latest:

Study: High Dose Ivermectin Not Effective for Outpatients With COVID-19

Results of the ACTIV-6 study showed that high dose ivermectin use did not demonstrate a clinical benefit for mild to moderate COVID-19.


Raymond Pascual, PharmD candidate

Latest:

Semaglutide Carries Potential Risk of Worsening Diabetic Retinopathy

Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.


Addy Howe, PharmD Candidate

Latest:

Hepatitis Awareness Month: Help Your Patients Live(r) Longer

Many of patients with hepatitis that pharmacists encounter have viral hepatitis, which can be easily remembered as the ABCs of hepatitis.


Lynnlee Okda, PharmD

Latest:

HSV Offers Promising Target for Preventive, Therapeutic Vaccines

Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.


Kay Yamamoto, PharmD

Latest:

Avoid Burnout During Times of Uncertainty

Organizations should focus on improving employee well-being and reducing workplace stressors.


Allison Kupsh, PharmD

Latest:

Immune Checkpoint Inhibitors Change Treatment Landscape for Metastatic Cervical Cancer

Approval of a novel antibody-drug conjugate ushers in new second-line option.


Paige Clark, RPh

Latest:

The Sooner the Better: Why Pharmacies Need a Smarter Pricing System Now

Your pharmacy’s bottom line needs a smarter pricing system to keep up with a tech-smart customer. But when should you make the move?


Keith Wellman, PharmD, BCPS, MBA

Latest:

Multiple Myeloma Pipeline Offers Promising New Options for Treatment

Novel therapeutics under investigation include CAR T-cell therapies, antibody-drug conjugates, and bispecific antibodies, as well as other unique drugs.


Amber Suthers, CPhT, MSAH, and Beth Bryan, PharmD

Latest:

Pharmacy Is Ready to Embrace Expanded Roles

Pandemic allows technicians to shine and be increasingly viewed as key to streamlining workflow.


Gauri Sabnis, PhD

Latest:

Case Study: Insulin Sensitizers as Enhancers in Diabetes Management

The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.


Gabrielle Ruggiero, PharmD, BCPS

Latest:

Oncology Overview: Tucatinib for Advanced Unresectable or Metastatic HER2-Positive Breast Cancer

Tucatinib is indicated to treat adults with advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer who have already received at least 1 anti-HER2-based regimen in the metastatic setting.


Allison T. Rhoads, PharmD

Latest:

Oncology Overview: Investigational Autologous TIL Immunotherapy LN-145 for Cervical Cancer

Studies suggest novel immunotherapy may have efficacy as monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.


Krishna Kurapati

Latest:

Accelerate Time to Specialty Pharmacy Therapy with Digital Options

Digitizing hub processes can create an efficient and effective tech-driven patient access strategy speeding access to lifesaving therapies.


Eric Berberian, PharmD candidate

Latest:

Semaglutide Carries Potential Risk of Worsening Diabetic Retinopathy

Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.


Amer El-Ghali, PharmD

Latest:

2022-2023 Influenza Season Looks to Be Severe

Outpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.


Todd Watkins

Latest:

Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health Outcomes

Additional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.


Javier Munoz, MD, MBA

Latest:

Future Treatment Landscape of MZL

Closing out their discussion on marginal zone lymphoma, the panel considers which future treatment strategies are most promising.


Ken Perez

Latest:

The Societal Case for Pharmacist Provider Status

Beyond the benefits to the pharmacist profession, granting provider status to pharmacists addresses the larger societal problem of growing physician shortages.


Bradley J. Monk, MD, FACS, FACOG

Latest:

Practice Pearl 3: Reducing Costs of PARPi for Ovarian Cancer Treatment

Experts in gynecologic oncology provide insight on available patient assistance programs to help lower costs of PARP inhibitors for the treatment of ovarian cancer, and how pharmacists can aid in obtaining this information.


Jenna Januszka, PharmD

Latest:

Monkeypox Treatment and Prevention: Stopping the Latest Outbreak

There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.


Anu Tirupasur

Latest:

Learn to Mitigate Feelings of Burnout and Stress

Lack of acknowledgement or rewards in high-pressure pharmacy environments can lead to mental health issues.



© 2023 MJH Life Sciences

All rights reserved.